Eylea 8mg intravitreal injection solution 114.3mg/mL

Eylea 8mg intravitreal injection solution 114.3mg/mL, manufactured by Bayer Pharmaceutical, contains aflibercept (genetical recombination) and is used to treat neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular edema (DME). This 8mg 0.07mL 1 bottle formulation (YJ code: 1319405A2023) works by inhibiting vascular endothelial growth factor (VEGF) to prevent abnormal blood vessel growth and leakage in the eye, which helps to stabilize and often impro…